News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Atlas Venture Fund IX, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/31/2023 |
SC 13G/A
| Atlas Venture Fund IX, L.P. reports a 4.9% stake in sURFACE ONCOLOGY, Inc. |
| 01/25/2022 |
SC 13G/A
| Atlas Venture Fund IX, L.P. reports a 2.3% stake in COGENT BIOSCIENCES |
| 01/25/2022 |
SC 13G/A
| Atlas Venture Fund IX, L.P. reports a 6.4% stake in sURFACE ONCOLOGY, Inc. |
| 01/25/2022 |
SC 13G/A
| Atlas Venture Fund IX, L.P. reports a 4.3% stake in spero therapeutics, Inc. |
| 02/02/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/02/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/02/2021 |
SC 13G/A
| Atlas Venture Fund IX, L.P. reports a 8.1% stake in COGENT BIOSCIENCES |
| 12/28/2020 |
SC 13D
| Atlas Venture Fund IX, L.P. reports a 8% stake in Skillz Inc. |
| 12/21/2020 |
4/A
| Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Sold 1,700,000 shares
@ $8.1, valued at
$13.8M
|
|
| 12/21/2020 |
4
| Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Sold 1,700,000 shares
@ $18.1, valued at
$30.8M
|
|
| 02/04/2020 |
SC 13G/A
| Atlas Venture Fund IX, L.P. reports a 11% stake in UNUM THERAPEUTICS, Inc. |
| 02/04/2020 |
SC 13G/A
| Atlas Venture Fund IX, L.P. reports a 16.7% stake in sURFACE ONCOLOGY, Inc. |
| 02/04/2020 |
SC 13G/A
| Atlas Venture Fund IX, L.P. reports a 7.2% stake in SPERO THERAPEUTICS, Inc. |
| 02/08/2019 |
SC 13G
| Atlas Venture Fund IX, L.P. reports a 11.2% stake in UNUM THERAPEUTICS, INC. |
| 02/08/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/08/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2019 |
SC 13G/A
| Atlas Venture Fund IX, L.P. reports a 7.6% stake in SPERO THERAPEUTICS, INC. |
| 04/23/2018 |
4
| Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Converted 3,181,817 shares
@ $0
Bought 100,000 shares
@ $15, valued at
$1.5M
Converted 7,000,000 preferred shares
@ $0 |
|
| 04/18/2018 |
3
| Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 3 on Surface Oncology, Inc. |
| 04/03/2018 |
4
| Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Converted 3,184,446 shares
@ $0
Converted 83,037 shares
@ $0
Bought 94,052 shares
@ $12, valued at
$1.1M
Converted 3,184,446 preferred shares
@ $0
Converted 83,037 preferred shares
@ $0 |
|
| 03/28/2018 |
3
| Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 3 on Unum Therapeutics, Inc. |
| 02/09/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/01/2017 |
3
| Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 3 on Spero Therapeutics, Inc. |
| 09/29/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/30/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2017 |
4
| Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Disposed of 700,000 shares
@ $0 |
|
| 02/09/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 05/11/2016 |
4
| Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Converted 611,827 shares
@ $0
Converted 2,463,201 shares
@ $0
Converted 862,120 shares
@ $0
Converted 492,640 shares
@ $0
Converted 946,237 options to buy
@ $0
Converted 3,809,524 preferred shares
@ $0
Converted 1,333,333 preferred shares
@ $0
Converted 761,905 preferred shares
@ $0 |
|
| 05/05/2016 |
3
| Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 3 on Intellia Therapeutics, Inc. |
|
|